Matthew Shair, Director at Nuvalent, Inc. (NUVL), sold 14,191 shares at $108.73 ($1.6M) on 2025-11-24, disclosed to the SEC on 2025-11-26.
Scheduled sale ($1.6M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $107.70 | 369 | $40K | 2.6% |
| 2 | $107.70 | 104 | $11K | 0.7% |
| 3 | $108.73 | 2,262 | $246K | 15.8% |
| 4 | $108.73 | 638 | $69K | 4.5% |
| 5 | $108.73 | 638 | $69K | 4.5% |
| 6 | $108.73 | 2,262 |
| $246K |
| 15.8% |
| 7 | $109.77 | 2,026 | $222K | 14.3% |
| 8 | $109.77 | 572 | $63K | 4.0% |
| 9 | $109.77 | 572 | $63K | 4.0% |
| 10 | $109.77 | 2,026 | $222K | 14.3% |
| 11 | $110.42 | 1,193 | $132K | 8.5% |
| 12 | $110.42 | 1,193 | $132K | 8.5% |
| 13 | $110.42 | 336 | $37K | 2.4% |
| Total | $109.40 avg | 14,191 | $1.6M | 100% |
| Filing → |
| NUVL | SELL | 2025-01-29 | $302K | — | Filing → |
| NUVL | SELL | 2024-12-26 | $285K | — | Filing → |
| NUVL | SELL | 2024-11-27 | $382K | — | Filing → |